Clinical Drug Investigation covers: Clinical trials Outcomes research Pharmacoeconomics studies Pharmacoepidemiology studies Pharmacodynamic and pharmacokinetic studies Application of drug-delivery technology in healthcare Clinical Drug Investigation offers a range of additional enhanced features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers in understanding important medical advances. The journal also provides the option to include various other types of enhanced features including slide sets, videos and animations. All enhanced features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
Clinical Drug Investigation
Description
Identifiers
ISSN | 1173-2563 |
e-ISSN | 1179-1918 |
DOI | 10.1007/40261.1179-1918 |
Publisher
Springer International Publishing
Additional information
Data set: Springer
Articles
Clinical Drug Investigation > 2019 > 39 > 12 > 1153-1174
Background Non-small cell lung cancer (NSCLC) is one of the most commonly diagnosed cancers. There are many published studies of cost-effectiveness analyses of licensed treatments, but no study has compared these studies or their approaches simultaneously. Objective To investigate the methodology used in published economic analyses of licensed interventions for previously treated advanced/metastatic...